Cross-blocking activity of specific antibodies induced by SLIT with RBet V 1

被引：0
|
作者：
Grilo, J. [1 ]
Aglas, L. [2 ]
Ferreira, F. [2 ]
Kinaciyan, T. [3 ]
Bohle, B. [1 ]
机构：
[1] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Pathophysiol & Allergy Res, Div Cellular Allergol, Vienna, Austria
[2] Univ Salzburg, Dept Biosci, Salzburg, Austria
[3] Med Univ Vienna, Dept Dermatol, Vienna, Austria
来源：
ALLERGY | 2019年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
TP1176
引用
收藏
页码：624 / 625
页数：2
相关论文
共 50 条
  • [31] BLOCKING ANTIBODIES SPECIFIC FOR HUMAN ALBUMIN INTERFERE WITH THE HEMOLYTIC-ACTIVITY OF THE MEMBRANE ATTACK COMPLEX OF COMPLEMENT
    HOULE, JJ
    HOFFMANN, EM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 200 (01) : 135 - 141
  • [32] Specific immunotherapy with recombinant birch pollen allergen rBet v 1-FV is clinically efficacious-results of a phase III study
    Kettner, J.
    Meyer, H.
    Narkus, A.
    Cromwell, O.
    Jost, K.
    ALLERGY, 2007, 62 : 33 - 33
  • [33] Specific immunotherapy with recombinant birch pollen allergen rBet v 1-FV results of 2 years of treatment (Phase II trial)
    Kettner, J.
    Meyer, H.
    Cromwell, O.
    Narkus, A.
    Jost, K.
    ALLERGY, 2007, 62 : 262 - 262
  • [34] Sublingual immunotherapy with rMald1 induces apple-allergen specific blocking antibodies
    Acosta, Sanchez G.
    Kinaciyan, T.
    Moebs, C.
    Pfuetzner, W.
    Bohle, B.
    ALLERGY, 2018, 73 : 160 - 160
  • [35] Specific Antibody Fragment Ligand Traps Blocking FGF1 Activity
    Chudzian, Julia
    Szlachcic, Anna
    Zakrzewska, Malgorzata
    Czub, Miroslawa
    Pustula, Marcin
    Holak, Tad A.
    Otlewski, Jacek
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (09)
  • [36] HLA MOLECULE-CYTOSKELETON ASSOCIATIONS INDUCED BY CROSS-LINKING WITH SPECIFIC ANTIBODIES
    HASKOVA, V
    IVASKOVA, E
    MACUROVA, H
    FOLIA BIOLOGICA, 1988, 34 (06) : 372 - +
  • [37] Characterization of the affinity of Mal d 1-specific IgG antibodies induced by sublingual immunotherapy with recombinant Bet v 1 or Mal d 1
    Strobl, M. R.
    Kitzmueller, C.
    Wangorsch, A.
    Lupinek, C.
    Acosta, Sanchez G.
    Kinaciyan, T.
    Bohle, B.
    ALLERGY, 2020, 75 : 130 - 131
  • [38] Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individuals
    Gorny, Miroslaw K.
    Pan, Ruimin
    Williams, Constance
    Wang, Xiao-Hong
    Volsky, Barbara
    O'Neal, Timothy
    Spurrier, Brett
    Sampson, Jared M.
    Li, Liuzhe
    Seaman, Michael S.
    Kong, Xiang-Peng
    Zolla-Pazner, Susan
    VIROLOGY, 2012, 427 (02) : 198 - 207
  • [39] Effect of natural HIV-1 envelope V1-V2 sequence diversity on the binding of V3-specific and non-V3-specific antibodies
    Rencher, SD
    Hurwitz, JL
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1997, 16 (02) : 69 - 73
  • [40] PLASMODIUM-FALCIPARUM - A COMPARISON OF THE ACTIVITY OF PFS230-SPECIFIC ANTIBODIES IN AN ASSAY OF TRANSMISSION-BLOCKING IMMUNITY AND SPECIFIC COMPETITION ELISAS
    ROEFFEN, W
    BECKERS, PJA
    TEELEN, K
    LENSEN, T
    SAUERWEIN, RW
    MEUWISSEN, JHET
    ELING, W
    EXPERIMENTAL PARASITOLOGY, 1995, 80 (01) : 15 - 26
12345